Segment Reporting (Tables)

9 Months Ended

Sep. 30, 2020

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment

Financial information relating to our reportable operating segments and reconciliations to the consolidated totals for the three and nine-month periods ended September 30, 2020 and 2019, were as follows (in thousands):

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
Net Sales
Cardiovascular	$	236,413	$	234,426	$	684,134	$	711,570
Endoscopy		7,562		8,623		21,737		25,360
Total net sales		243,975		243,049		705,871		736,930
Operating Income (Loss)
Cardiovascular		(1,702)		(6,210)		(20,662)		11,263
Endoscopy		1,766		3,329		3,093		7,581
Total operating income (loss)		64		(2,881)		(17,569)		18,844
Total other expense - net		(2,248)		(2,809)		(8,907)		(8,689)
Income tax (benefit) expense		825		(2,292)		(1,255)		499
Net income (loss)	$	(3,009)	$	(3,398)	$	(25,221)	$	9,656